Pharma Journalist -

Ascentage Pharma announced that the U.S. Food and Drug Administration (FDA) has accepted the Investigational New Drug (IND) application for APG-1387, a novel small molecule IAP…
Read More...

Arvinas LLC announced it has expanded its ongoing license agreement with Genentech, a member of the Roche Group, for the development of new therapeutics using Arvinas' novel PROTAC…
Read More...

SMi reports: Abbvie and Astrazeneca to present keynote address’ at SMi’s Drug Discovery conference taking place in London on 21st-22nd March 2018 Abbvie and Astrazeneca will present…
Read More...

Evonik is expanding its RESOMER portfolio of bioresorbable polymers for controlled-release parenteral drug formulations. It now offers RESOMER Zero and RESOMER Sterile versions of both…
Read More...

Theravance Biopharma and Mylan announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for revefenacin (TD-4208), an investigational…
Read More...

Allergan plc announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for VRAYLAR™ (cariprazine) for the maintenance…
Read More...

Absorption Systems announces the acquisition of TGA Sciences, Inc., a contract R&D laboratory located in Medford, MA, just outside the pharma/biotech hub of Cambridge. TGA Sciences,…
Read More...

Excision BioTherapeutics, a life science company focused on the development and commercialization of advanced gene editing therapeutics for the treatment of life-threatening disease…
Read More...

Avista Pharma Solutions, Inc. has completed facility upgrades that effectively double the company’s API manufacturing capacity at its Longmont, Colorado site. During this expansion, the…
Read More...

Zymeworks announced that it has executed a licensing agreement with Janssen Biotech. The deal was facilitated by Johnson & Johnson Innovation. Under the terms of the licensing…
Read More...